In male Shank3 KO mice, acute intraperitoneal Lamotrigine administration decreased exploration preference in the textured zone. In a separate study in male Shank3 KO mice, acute intraperitoneal Lamotrigine injection produced no difference in NREM sleep bout length compared with vehicle. In naïve Scn1a +/− mice, Lamotrigine administered through supplemented chow completely prevented lethality compared with untreated mice. [2,3]
Lamotrigine and textured-zone exploration in Shank3 KO mice
Animal study · 8–12-week male Shank3 KO; C57BL/6J background; n = 9 mice for all groups [2]
In male Shank3 KO mice, acute intraperitoneal Lamotrigine administration decreased exploration preference in the textured zone.
Conditions shared by the study groups
- Route
- intraperitoneal injected
- Treatment course
- acute administration
- Vehicle
- 2% DMSO in saline
- Lamotrigine 20 mg/kg
- Model: 8–12-week male Shank3 KO; C57BL/6J background; n = 9 mice for all groups
Methods and source locations
Compound reported in the paper: Lamotrigine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
STAR★Methods > Experimental model and study participant details > Animal studies (S121); STAR★Methods > Method details > Behavioral tests (S195); Figure 5 legend (S307)
discrimination score for the textured zone: discrimination score for the textured zone; comparator: vehicle — Figure 5 legend (S307)
Lamotrigine 20 mg/kg · STAR★Methods > Method details > Behavioral tests (S195); Figure 5 legend (S307)
Survival in Scn1a +/− Mice During Lamotrigine Treatment
Animal study · Scn1a +/− mice [3]
Lamotrigine (125 mg per kg of chow); naïve Scn1a +/− mice; Treatment began at P18 and survival was monitored until P42. Lamotrigine treatment significantly improved survival compared to untreated mice.
Conditions shared by the study groups
- Route
- orally through supplementation in chow
- Treatment course
- Treatment began at P18 and survival was monitored until P42
- Vehicle
- Purina 5LOD
- Lamotrigine 125 mg per kg of chow
- Model: Scn1a +/− mice
Methods and source locations
Compound reported in the paper: Lamotrigine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Spontaneous seizure frequency monitoring (S54, S55); Results > Survival analysis (S155, S156, S157); Figure 7 legend (S206, S210)
6‐week survival: 6‐week survival; comparator: untreated Scn1a +/− mice — Materials and Methods > Spontaneous seizure frequency monitoring (S55); Results > Survival analysis (S156, S157); Figure 7 legend (S206, S210)
Lamotrigine 125 mg per kg of chow · Materials and Methods > Spontaneous seizure frequency monitoring (S54, S55); Results > Survival analysis (S157); Figure 7 legend (S206, S210)
Lamotrigine and NREM sleep bouts in Shank3 KO mice
Animal study · 8–12-week male Shank3 KO; C57BL/6J background; n = 8 mice for all groups [2]
In male Shank3 KO mice, acute intraperitoneal Lamotrigine injection produced no difference in NREM sleep bout length compared with vehicle.
Conditions shared by the study groups
- Route
- intraperitoneal injected
- Treatment course
- acute injection
- Vehicle
- 2% DMSO in saline
- Lamotrigine 20 mg/kg
- Model: 8–12-week male Shank3 KO; C57BL/6J background; n = 8 mice for all groups
Methods and source locations
Compound reported in the paper: Lamotrigine
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
STAR★Methods > Experimental model and study participant details > Animal studies (S121); STAR★Methods > Method details > Stereotaxic surgery (S178, S181); STAR★Methods > Method details > Behavioral tests (S195); Figure 5 legend (S307)
NREM sleep bout length: NREM sleep bout length; comparator: vehicle — Figure 5 legend (S307)
Lamotrigine 20 mg/kg · STAR★Methods > Method details > Behavioral tests (S195); Figure 5 legend (S307)